[1]
S. Afzal, “Neuroendocrine Tumors, Possible Targets for Tyrosine Kinase Inhibitor Therapy”, Int J Pathol, vol. 17, no. 4, pp. 156–161, Jun. 2020, Accessed: Apr. 30, 2025. [Online]. Available: https://www.jpathology.com/index.php/OJS/article/view/514